Improved survival using specialized multidisciplinary board in sarcoma patients-Reference-Cited by-同舟云学术

Improved survival using specialized multidisciplinary board in sarcoma patients

Published:2017-11 Issue:11 Volume:28 Page:2852-2859
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Blay J.-Y.^ORCID,Soibinet P.,Penel N.,Bompas E.,Duffaud F.,Stoeckle E.,Mir O.,Adam J.,Chevreau C.,Bonvalot S.,Rios M.,Kerbrat P.,Cupissol D.,Anract P.,Gouin F.,Kurtz J. -E.,Lebbe C.,Isambert N.,Bertucci F.,Toumonde M.,Thyss A.,Piperno-Neumann S.,Dubray-Longeras P.,Meeus P.,Ducimetière F.,Giraud A.,Coindre J. -M.,Ray-Coquard I.,Italiano A.,Le Cesne A.

Funder

National Cancer Institute

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/28/11/2852/24168929/mdx484.pdf

Reference25 articles.

1. Incidence of sarcoma histotypes and molecular subtypes in a prospective epidemiological study with central pathology review and molecular testing;Ducimetière;PLoS One,2011

2. A European project on incidence, treatment, and outcome of sarcoma;Mastrangelo;BMC Public Health,2010

3. The RARECARE Working Group Descriptive epidemiology of sarcomas in Europe: report from the RARECARE project;Stiller;Eur J Cancer,2013